Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience

Nusinersen (ISIS-SMN(Rx) or ISIS 396443) is an antisense oligonucleotide drug administered intrathecally to treat spinal muscular atrophy. We summarize lumbar puncture experience in children with spinal muscular atrophy during a phase 1 open-label study of nusinersen and its extension. During the st...

Descripción completa

Detalles Bibliográficos
Autores principales: Haché, Manon, Swoboda, Kathryn J., Sethna, Navil, Farrow-Gillespie, Alan, Khandji, Alexander, Xia, Shuting, Bishop, Kathie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871174/
https://www.ncbi.nlm.nih.gov/pubmed/26823478
http://dx.doi.org/10.1177/0883073815627882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871174/
https://www.ncbi.nlm.nih.gov/pubmed/26823478
http://dx.doi.org/10.1177/0883073815627882

Ejemplares similares